Glaucoma trials in United States

In United States 98 Also abroad 240

98 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Where
El Paso, Grand Junction, Oklahoma City
Age
18 years and over
People
110
Run by
Glaukos Corporation
See details and how to joinNCT07075718
No phaseEnrolling by invitation
Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT
Where
Charleston
Age
18 years and over
People
51
Run by
Medical University of South Carolina
See details and how to joinNCT06925477
No phaseTaking people
Functional and Structural Imaging for Glaucoma
Where
Portland
Age
40 years to 85 years
People
249
Run by
Oregon Health and Science University
See details and how to joinNCT01957267
No phaseTaking people
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Incentives
Where
Oakland, San Francisco
Age
50 years and over
People
2,000
Run by
University of California, San Francisco
See details and how to joinNCT07755748
No phaseTaking people
The Glaucoma and Retinopathy Screening Study
Where
Boston, Chelsea, Lynn, Salem, Saugus
Age
40 years and over
People
2,000
Run by
Massachusetts Eye and Ear Infirmary
See details and how to joinNCT06882356
No phaseEnrolling by invitation
Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty
Where
Salt Lake City
Age
18 years and over
People
100
Run by
University of Utah
See details and how to joinNCT07073937
No phaseNot yet taking people in United States
Know Your Pressures NYC
Where
New York
Age
40 years and over
People
7,085
Run by
Columbia University
See details and how to joinNCT05992415
No phaseEnrolling by invitation
Smart Soft Contact Lenses for Monitoring Glaucoma
Where
Bloomington
Age
22 years and over
People
120
Run by
Indiana University
See details and how to joinNCT07224542
No phaseTaking people
A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
Where
Boston
Age
20 years to 79 years
People
90
Run by
Massachusetts General Hospital
See details and how to joinNCT07780890
Phase 3Taking people
Clarifying the Optimal Application of SLT Therapy Trial
Where
Ann Arbor, Baltimore, Boston, Chicago, Cleveland, Detroit, Fort Worth, Kingston, Laguna Hills, Lakeworth, Madison, Morgantown, Nashville, Orland Park, Pasadena, Peoria, Philadelphia, Pittsburgh, Portland, Reading, Sacramento, San Francisco, Sheridan, Spokane, The Bronx
Age
18 years and over
People
790 worldwide
Run by
University of Pittsburgh
See details and how to joinNCT04967989
No phaseTaking people
Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy
Where
Baltimore
Age
18 years and over
People
60
Run by
University of Maryland, Baltimore
See details and how to joinNCT06993597
No phaseTaking people
Optimize Pediatric OCT Imaging
Where
Durham
People
30
Run by
Duke University
See details and how to joinNCT06139523
No phaseEnrolling by invitation
5-Year Postoperative Outcomes of Patients Who Completed the CREST Study
Where
Atlanta, Cape Coral, Chevy Chase, Crossville, DeLand, Fort Washington, Las Vegas, Newport Beach, Rockville, Salt Lake City
People
250
Run by
Iantrek, Inc.
See details and how to joinNCT07480343
No phaseTaking people
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Where
Baltimore, Boston, Buffalo, Chapel Hill, Miami, San Francisco, Walnut Creek
Age
18 years and over
People
226 worldwide
Run by
University of Pennsylvania
See details and how to joinNCT05924477
Early phase 1Taking people
Optic Nerve Head Strain in Non-glaucoma Subjects
Where
Baltimore
Age
30 years to 90 years
People
30
Run by
Johns Hopkins University
See details and how to joinNCT07425535
Phase 4Taking people
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
Where
Baltimore, Columbia, Silver Spring
Age
18 years and over
People
50
Run by
University of Maryland, Baltimore
See details and how to joinNCT04401982
No phaseTaking people
Ocular Blood Flow Imaging for Glaucoma Assessment
Where
Baltimore
Age
18 years to 88 years
People
150
Run by
University of Maryland, Baltimore
See details and how to joinNCT05726058
No phaseTaking people
Stem Cell Ophthalmology Treatment Study II
Where
Coral Springs, Westport
Age
18 years and over
People
500 worldwide
Run by
MD Stem Cells
See details and how to joinNCT03011541
No phaseNot yet taking people in United States
Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries
Where
Detroit
Age
18 years and over
People
132
Run by
Henry Ford Health System
See details and how to joinNCT07418853
Phase 4Taking people
Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension
Where
Bloomington
Age
18 years and over
People
50
Run by
Indiana University
See details and how to joinNCT07588152
No phaseTaking people
Village-Integrated Eye Worker Trial II
Where
San Francisco
Age
60 years and over
People
60,200
Run by
University of California, San Francisco
See details and how to joinNCT03752840
Phase 4Taking people
Travoprost Intraocular Implant + iStent Infinite
Where
Oklahoma City
Age
18 years and over
People
150
Run by
Glaukos Corporation
See details and how to joinNCT06066645
No phaseTaking people
Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease
Where
Durham
Age
4 years to 21 years
People
1,000
Run by
Duke University
See details and how to joinNCT05150197
Phase 4Taking people
Rocklatan vs Latanoprost Post-DSLT
Where
Beaumont
Age
18 years and over
People
36
Run by
Eye Centers of Southeast Texas
See details and how to joinNCT07465913
Phase 1Taking people
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Where
Boston, Charleston, Glendale, New York
Age
40 years to 85 years
People
18
Run by
Life Biosciences Inc.
See details and how to joinNCT07290244